Manish K Gupta1, James Gulick1, Ruijie Liu1, Xuejun Wang1, Jeffery D Molkentin1, Jeffrey Robbins2. 1. From the Heart Institute, Department of Pediatrics, The Cincinnati Children's Hospital Medical Center, OH (M.K.G., J.G., R.L., J.D.M., J.R.); and Division of Basic Biomedical Sciences, Sanford School of Medicine of the University of South Dakota, Vermillion (X.W.). 2. From the Heart Institute, Department of Pediatrics, The Cincinnati Children's Hospital Medical Center, OH (M.K.G., J.G., R.L., J.D.M., J.R.); and Division of Basic Biomedical Sciences, Sanford School of Medicine of the University of South Dakota, Vermillion (X.W.). jeff.robbins@cchmc.org.
Abstract
RATIONALE: Impairment of proteasomal function is pathogenic in several cardiac proteinopathies and can eventually lead to heart failure. Loss of proteasomal activity often results in the accumulation of large protein aggregates. The ubiquitin proteasome system (UPS) is primarily responsible for cellular protein degradation, and although the role of ubiquitination in this process is well studied, the function of an ancillary post-translational modification, SUMOylation, in protein quality control is not fully understood. OBJECTIVE: To determine the role of ubiquitin-conjugating enzyme 9 (UBC9), a small ubiquitin-like modifier-conjugating enzyme, in cardiomyocyte protein quality control. METHODS AND RESULTS: Gain- and loss-of-function approaches were used to determine the importance of UBC9. Overexpression of UBC9 enhanced UPS function in cardiomyocytes, whereas knockdown of UBC9 by small interfering RNA caused significant accumulations of aggregated protein. UPS function and relative activity was analyzed using a UPS reporter protein consisting of a short degron, CL1, fused to the COOH-terminus of green fluorescent protein (GFPu). Subsequently, the effects of UBC9 on UPS function were tested in a proteotoxic model of desmin-related cardiomyopathy, caused by cardiomyocyte-specific expression of a mutated αB crystallin, CryAB(R120G). CryAB(R120G) expression leads to aggregate formation and decreased proteasomal function. Coinfection of UBC9-adenovirus with CryAB(R120G) virus reduced the proteotoxic sequelae, decreasing overall aggregate concentrations. Conversely, knockdown of UBC9 significantly decreased UPS function in the model and resulted in increased aggregate levels. CONCLUSIONS: UBC9 plays a significant role in cardiomyocyte protein quality control, and its activity can be exploited to reduce toxic levels of misfolded or aggregated proteins in cardiomyopathy.
RATIONALE: Impairment of proteasomal function is pathogenic in several cardiac proteinopathies and can eventually lead to heart failure. Loss of proteasomal activity often results in the accumulation of large protein aggregates. The ubiquitin proteasome system (UPS) is primarily responsible for cellular protein degradation, and although the role of ubiquitination in this process is well studied, the function of an ancillary post-translational modification, SUMOylation, in protein quality control is not fully understood. OBJECTIVE: To determine the role of ubiquitin-conjugating enzyme 9 (UBC9), a small ubiquitin-like modifier-conjugating enzyme, in cardiomyocyte protein quality control. METHODS AND RESULTS: Gain- and loss-of-function approaches were used to determine the importance of UBC9. Overexpression of UBC9 enhanced UPS function in cardiomyocytes, whereas knockdown of UBC9 by small interfering RNA caused significant accumulations of aggregated protein. UPS function and relative activity was analyzed using a UPS reporter protein consisting of a short degron, CL1, fused to the COOH-terminus of green fluorescent protein (GFPu). Subsequently, the effects of UBC9 on UPS function were tested in a proteotoxic model of desmin-related cardiomyopathy, caused by cardiomyocyte-specific expression of a mutated αB crystallin, CryAB(R120G). CryAB(R120G) expression leads to aggregate formation and decreased proteasomal function. Coinfection of UBC9-adenovirus with CryAB(R120G) virus reduced the proteotoxic sequelae, decreasing overall aggregate concentrations. Conversely, knockdown of UBC9 significantly decreased UPS function in the model and resulted in increased aggregate levels. CONCLUSIONS:UBC9 plays a significant role in cardiomyocyte protein quality control, and its activity can be exploited to reduce toxic levels of misfolded or aggregated proteins in cardiomyopathy.
Authors: Rakez Kayed; Elizabeth Head; Jennifer L Thompson; Theresa M McIntire; Saskia C Milton; Carl W Cotman; Charles G Glabe Journal: Science Date: 2003-04-18 Impact factor: 47.728
Authors: Xin Dong; Jinbao Liu; Hanqiao Zheng; Joseph W Glasford; Wei Huang; Quan Hai Chen; Niels R Harden; Faqian Li; A Martin Gerdes; Xuejun Wang Journal: Am J Physiol Heart Circ Physiol Date: 2004-04-22 Impact factor: 4.733
Authors: Benjamin J Wilkins; Yan-Shan Dai; Orlando F Bueno; Stephanie A Parsons; Jian Xu; David M Plank; Fred Jones; Thomas R Kimball; Jeffery D Molkentin Journal: Circ Res Date: 2003-12-01 Impact factor: 17.367
Authors: Atsushi Sanbe; Hanna Osinska; Jeffrey E Saffitz; Charles G Glabe; Rakez Kayed; Alina Maloyan; Jeffrey Robbins Journal: Proc Natl Acad Sci U S A Date: 2004-06-25 Impact factor: 11.205
Authors: Manish K Gupta; Farzaneh G Tahrir; Tijana Knezevic; Martyn K White; Jennifer Gordon; Joseph Y Cheung; Kamel Khalili; Arthur M Feldman Journal: J Cell Biochem Date: 2016-01-21 Impact factor: 4.429
Authors: Patrick M McLendon; Gregory Davis; James Gulick; Sonia R Singh; Na Xu; Nathan Salomonis; Jeffery D Molkentin; Jeffrey Robbins Journal: Circ Res Date: 2017-06-27 Impact factor: 17.367
Authors: Diederik W D Kuster; Thomas L Lynch; David Y Barefield; Mayandi Sivaguru; Gina Kuffel; Michael J Zilliox; Kyoung Hwan Lee; Roger Craig; Rajasekaran Namakkal-Soorappan; Sakthivel Sadayappan Journal: Cardiovasc Res Date: 2019-12-01 Impact factor: 10.787
Authors: Manish K Gupta; Patrick M McLendon; James Gulick; Jeanne James; Kamel Khalili; Jeffrey Robbins Journal: Circ Res Date: 2016-05-03 Impact factor: 17.367